Mar­tin Shkre­li can't de­lay $25M pay­ment over an­ti­com­pet­i­tive case, judge rules

The judge over­see­ing Mar­tin Shkre­li’s civ­il case over his no­to­ri­ous price hike of a life­sav­ing drug isn’t in a for­giv­ing mood.

Shkre­li had asked to de­lay pay­ing $24.6 mil­lion as part of a judg­ment — which al­so bans the “Phar­ma Bro” from the phar­ma­ceu­ti­cal in­dus­try for life — while he pre­pares to file an ap­peal. But Judge Denise Cote de­nied his bid.

In­fa­mous for jack­ing up the price of the an­tipar­a­sitic drug Dara­prim by 4000% overnight (and show­ing no re­morse what­so­ev­er), Shkre­li how­ev­er faced his first le­gal con­se­quences over an un­re­lat­ed crim­i­nal case of se­cu­ri­ties fraud in­volv­ing his in­vestors. While serv­ing his sev­en-year prison term, though, the FTC and sev­en states gath­ered enough ev­i­dence to file a civ­il law­suit over what they said was an an­ti­com­pet­i­tive scheme to de­lay the en­try of Dara­prim gener­ics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER